LAUSR

Topical ferumoxytol nanoparticles disrupt biofilms and prevent tooth decay in vivo via intrinsic catalytic activity

Sign Up to like & get
recommendations!
0 Published in 2018 at "Nature Communications"

DOI: 10.1038/s41467-018-05342-x

Abstract: Ferumoxytol is a nanoparticle formulation approved by the U.S. Food and Drug Administration for systemic use to treat iron deficiency. Here, we show that, in addition, ferumoxytol disrupts intractable oral biofilms and prevents tooth decay… read more here.

Keywords: ferumoxytol nanoparticles; tooth decay; ferumoxytol; topical ferumoxytol ... See more keywords